VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Research and development, 2025
- $345M
- YoY, 2025
- +239.4%
- 5-year CAGR
- +61.0%
- 10-year CAGR
- +47.7%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $345M | +239.4% |
| 2024 | $102M | +59.3% |
| 2023 | $64M | +17.6% |
| 2022 | $54M | +20.6% |
| 2021 | $45M | +40.9% |
| 2020 | $32M | +35.5% |
| 2019 | $24M | +23.7% |
| 2018 | $19M | +38.6% |
| 2017 | $14M | +52.7% |
| 2016 | $9.0M | +29.2% |
| 2015 | $7.0M | −68.7% |
| 2014 | $22M | — |